Now home to 5 of the top 7 big pharma companies in the MedTech sector, Costa Rica has increasingly become LATAM’s ideal location for the pharmaceutical industries.
A hub for strategic suppliers, medical devices, R&D activities and clinical studies, Costa Rica has emerged as the top choice for deploying a series of complex high-added-value processes.
Leveraging operational enhancement through drug testing & clinical trials, to patient data analytics, pharmacovigilance, manufacturing, and packaging, Costa Rica has emerged as the top choice for deploying a series of complex high-added-value processes.
Watch free of charge for this exclusive on-demand Investment Monitor webinar, in association with CINDE, to learn why Costa Rica has become such a sought-after nearshoring destination directly from companies already established and prospering in the country.
